Shamim Shamim

About

Shamim is a highly qualified academician with over nine years of teaching and research experience in pharmaceutical sciences. Currently serving as an Associate Professor at School of Pharmaceutical Sciences. His extensive expertise spans advanced drug delivery systems, nanotechnology, herbal therapeutics, and neuropharmacology. His strong research profile is reflected in his numerous publications in Scopus- and SCI-indexed journals, along with patents and significant contributions to books and book chapters. His active involvement in postgraduate research supervision, peer review activities, and participation in national and international academic conferences further reinforces his ability to provide credible, insightful, and scholarly contributions to the field.

Employment

• IIMT University Meerut Associate Professor
  2022 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (37)

• Unraveling Phytopharmacological Insights into Scutellaria barbata (Ban Zhi Lian) for Anticancer Therapy: Bridging Traditional Chinese Medicine and Modern Pharmacology
  The Natural Products Journal 2026 DOI: 10.2174/0122103155441553260627221842
  +Save
• Graphene Quantum Dots in Cancer Diagnostics and Therapeutics: Advances in Biosensing, Imaging, and Treatment Applications
  Current Medical Science 2026 DOI: 10.1007/s11596-025-00155-8
  +Save
• Chromatography and Spectroscopic Technique-based Rapid Characterization of Nano-carrier Pharmaceuticals
  Pharmaceutical Nanotechnology 2026 DOI: 10.2174/0122117385319695240911115239
  +Save
• Revolutionizing Drug and Gene Delivery: Cutting-Edge Smart Polymers for Precision Release
  Current Gene Therapy 2026 DOI: 10.2174/0115665232390238251121074917
  +Save
• Stimuli-Responsive Carbon Nanotubes for On-Demand Cancer Therapy: A Review
  AAPS PharmSciTech 2026 DOI: 10.1208/s12249-026-03391-w
  +Save
• Mechanistic Insights and Therapeutic Advances in Natural Bioactive Compounds as Multi-Target Agents in Rheumatoid Arthritis
  Current Rheumatology Reviews 2026 DOI: 10.2174/0115733971409871251206061614
  +Save
• CFTR mRNA-Based Gene Therapy for Cystic Fibrosis: A Mutation-Agnostic Strategy to Restore Ion Transport Function
  Current Gene Therapy 2026 DOI: 10.2174/0115665232413980251103133741
  +Save
• An Innovative Naproxen Nanosuspension Strategy for Targeted Drug Delivery in Glomerulonephritis
  Drug Delivery Letters 2026 DOI: 10.2174/0122103031423076260215052407
  +Save
• The RhoA/ROCK pathway in vascular dysfunction and inflammation: Mechanisms and therapeutic targeting
  European Journal of Inflammation 2026 DOI: 10.1177/1721727x261441093
  +Save
• Nanocarrier Mediated Delivery of Gepotidacin: A Novel Triazaacenaphthylene Antibiotic Targeting Drug-Resistant Bacterial Infections
  Anti-Infective Agents 2026 DOI: 10.2174/0122113525430497251211145738
  +Save